Clinical trialNCT02013310CompletedPhase 2Interventional

HT-0712 vs. Placebo in Subjects With Age-Associated Memory Impairment (AAMI)

SponsorDart NeuroScience, LLCEnrollment119Age-Associated Memory Impairment (AAMI)

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a Phase 2 randomized, multicenter, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy of HT-0712 in improving memory and cognitive performance in subjects with Age-Associated Memory Impairment (AAMI)

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Philip Perera, MD
Dart NeuroScience, LLC
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Facility name not stated
Sun City, Arizona, United States
Facility name not stated
Long Beach, California, United States
Facility name not stated
Santa Monica, California, United States
Facility name not stated
Denver, Colorado, United States
Facility name not stated
Atlantis, Florida, United States
Facility name not stated
Brooksville, Florida, United States
Facility name not stated
Tampa, Florida, United States
Facility name not stated
Marlton, New Jersey, United States
Facility name not stated
Princeton, New Jersey, United States
Facility name not stated
New York, New York, United States
Facility name not stated
Dayton, Ohio, United States
Facility name not stated
Tulsa, Oklahoma, United States
Facility name not stated
Cordova, Tennessee, United States
Facility name not stated
Austin, Texas, United States
Facility name not stated
San Antonio, Texas, United States
Facility name not stated
Salt Lake City, Utah, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

HT-0712Placebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Dec 2013
Primary completion: 31 Jan 2015
Completion: 31 Jan 2015
Last update posted: 30 Dec 2015
Registered enrollment: 119
Registry id: NCT02013310

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.